Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
elotuzumab
×
30 days
×
Clear all
Filters
3
NCT06158841
2026-03-13
CERVINO
AbbVie
Phase 3
Recruiting
380 enrolled
NCT06208150
2026-03-13
MonumenTAL-6
Janssen Research & Development, LLC
Phase 3
Recruiting
795 enrolled